Bio-gene Technology Ltd. · ASX:BGT
Bio-gene Technology — Corporate Update (February 2023)
16 slides from Bio-gene Technology's corporate update, Feb 23, 2023
Slide 1: Updated Company Presentation – February 2023 (ASX Announcement)
ASX ANNOUNCEMENT 23 FEBRUARY 2023 UPDATED COMPANY PRESENTATION – FEBRUARY 2023 Bio-Gene Technology Limited (ASX: BGT, “Bio-Gene”) is releasing the attached Updated Company Presentation in anticipation of a series of ongoing Company briefings which will take place over the next couple of weeks. The P
Slide 2: Bio-Gene Technology Limited: Enabling the Next Generation of Novel Insecticides
ENABLING THE NEXT GENERATION OF NOVEL INSECTICIDES BIO-GENE TECHNOLOGY LIMITED Addressing the needs of an impending catastrophic problem of pest resistance through the development of unique chemistry PRESENTED BY Richard Jagger CEO
Slide 3: Disclaimer
DISCLAIMER This presentation has been prepared by Bio-Gene Technology Limited (ASX:BGT) (the Company). This presentation is not, and should not be considered, an offer or invitation to apply for or purchase securities in the Company or as a recommendation or inducement to make an offer or invitation
Slide 4: Our Value Proposition
Investment Highlights OUR VALUE Bio-Gene has a Compelling Value Proposition PROPOSITION VISION: We want to contribute to a world that provides a viable future with Third-party validation of Natural chemistry is enhanced quality of life for In late 2022 confirmed technology by multiple significantly
Slide 5: Our Strategic Objective
OUR STRATEGIC Bring our unique chemistry to market in partnership with major players and generate multiple revenue streams from technology OBJECTIVE licensing fees, milestone payments and royalties by Securing the active ingredient product registrations Working with strong commercial partners on pro
Slide 6: Addressing Significant Global Challenges
Food Security & Public Health Growing Population Current global population is 8 billion, growing at 70 million p.a. It is ADDRESSING Challenges Of anticipated that global population will reach nearly 10 billion by 2050 1. Climbing average temperatures & other weather events impact food SIGNIFICANT G
Slide 7: Our Technology Addresses These Challenges and Targets Growing Global Markets
OUR TECHNOLOGY ADDRESSES THESE CHALLENGES AND TARGETS GROWING GLOBAL MARKETS Bio-Gene’s insecticide platform has potential Crop Protection Food, Fibre & Grain application in large, global market segments Storage 52% estimated to represent a total addressable market Includes grain storage segment, va
Slide 8: Our Technology Platform
OUR TECHNOLOGY PLATFORM We are developing two products that allow entry into five key market segments QcideTM FlavocideTM Natural Compound Nature Identical Compound Both of our products An extract of a specific cultivar of BGT has developed a proprietary have potential application eucalypt, the Gypm
Slide 9: Current Partnership - Public Health: Clarke Mosquito Control
CURRENT PARTNERSHIP - PUBLIC HEALTH: CLARKE MOSQUITO CONTROL Clarke is the largest vertically integrated company in public health mosquito control Market Opportunity Initial Field of Use: Results of Phase 2 Testing Commercial Development Next Steps US$100m1 Agreement Signed Very positive results ind
Slide 10: Current Partnership - Consumer Products: Evergreen Garden Care
CURRENT PARTNERSHIP - CONSUMER PRODUCTS: EVERGREEN GARDEN CARE Evergreen is a market leader in consumer products across Europe and in Australia/New Zealand Market Opportunity Initial Field of Use Other market opportunities Next Steps Fly & mosquito electric evaporator With Evergreen we are actively
Slide 11: New Agreement Signed with STK Bio-Ag
NEW AGREEMENT SIGNED WITH STK BIO-AG CROP PROTECTION, AQUACULTURE & PROFESSIONAL TURF Key Value Points for Bio-Gene Licencing arrangements Registering Active Ingredient Opportunities to expand manufacturing capabilities Bio-Gene grant STK a world-wide non- Under the agreement, STK will fully exclusi
Slide 12: Other Additional Opportunities: Stored Grain Project
OTHER ADDITIONAL OPPORTUNITIES STORED GRAIN PROJECT Grains Research and Development Corporation (GRDC) Department of Agriculture and Fisheries - Queensland (DAF) Field testing completed Nov/Dec 2021 Results of Phase 3 testing Further Discussions Final reporting on these results reported in Data show
Slide 13: Expected Key Valuation Catalysts - Next 6 to 24 Months
EXPECTED KEY VALUATION CATALYSTS - NEXT 6 TO 24 MONTHS STK signing & commencement Likelihood of significant non dilutive financings Additional IP filings Publication of key update efficacy & Mode of Action data Additional commercial partnerships Advancing our Clarke results regulatory Manufacturing
Slide 14: A Clear Road Map for Generating Value 2024-2026
A CLEAR ROAD MAP FOR GENERATING VALUE 2024-2026 – MEDIUM TERM 2022-2024 2021-2022 • First regulatory approval and • Additional 2020-2021 application testing - commercial sales internal and with • Additional 2018-2020 • Manufacturing scale- partners registration up of Flavocide & submissions • Conver
Slide 15: Summary
SUMMARY • New Mode of Action and “nature identical” technology that delivers solutions critical for pest management globally • Business model based on controlling IP and registration / partnering with majors. • Bio-Gene now has commercial validation from three key companies in different market segme
Slide 16: Thank You
ENABLING THE NEXT GENERATION OF NOVEL INSECTICIDES BIO-GENE TECHNOLOGY LIMITED THANK YOU richardj@bio-gene.com.au www.bio-gene.com.au
Bio-gene Technology — Corporate Update (February 2023) on 6ix